BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25652350)

  • 1. Evaluation of ibuprofen loaded solid lipid nanoparticles and its combination regimens for pancreatic cancer chemoprevention.
    Thakkar A; Chenreddy S; Wang J; Prabhu S
    Int J Oncol; 2015 Apr; 46(4):1827-34. PubMed ID: 25652350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen.
    Sutaria D; Grandhi BK; Thakkar A; Wang J; Prabhu S
    Int J Oncol; 2012 Dec; 41(6):2260-8. PubMed ID: 23007664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loratadine self-microemulsifying drug delivery systems (SMEDDS) in combination with sulforaphane for the synergistic chemoprevention of pancreatic cancer.
    Desai P; Thakkar A; Ann D; Wang J; Prabhu S
    Drug Deliv Transl Res; 2019 Jun; 9(3):641-651. PubMed ID: 30706304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles.
    Thakkar A; Chenreddy S; Wang J; Prabhu S
    Cell Biosci; 2015; 5():46. PubMed ID: 26301084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Arch Pharm Res; 2017 Dec; 40(12):1420-1432. PubMed ID: 29027133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, in vitro and in vivo Evaluation of Thermosensitive in situ Gel Loaded with Ibuprofen-Solid Lipid Nanoparticles for Rectal Delivery.
    Huang CH; Hu PY; Wu QY; Xia MY; Zhang WL; Lei ZQ; Li DX; Zhang GS; Feng JF
    Drug Des Devel Ther; 2022; 16():1407-1431. PubMed ID: 35586185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer.
    Thakkar A; Sutaria D; Grandhi BK; Wang J; Prabhu S
    Oncol Rep; 2013 Apr; 29(4):1671-7. PubMed ID: 23404329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility.
    Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D
    J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel nano-drug combination therapeutic regimen demonstrates significant efficacy in the transgenic mouse model of pancreatic ductal adenocarcinoma.
    Thakkar A; Desai P; Chenreddy S; Modi J; Thio A; Khamas W; Ann D; Wang J; Prabhu S
    Am J Cancer Res; 2018; 8(10):2005-2019. PubMed ID: 30416852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.
    Grandhi BK; Thakkar A; Wang J; Prabhu S
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1015-1025. PubMed ID: 24072676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice.
    Thakkar A; Chenreddy S; Thio A; Khamas W; Wang J; Prabhu S
    Int J Nanomedicine; 2016; 11():3265-76. PubMed ID: 27499621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of topical ibuprofen solid lipid nanoparticle (SLN) gel using hot melt extrusion technique (HME) and determining its anti-inflammatory strength.
    Bagde A; Patel K; Kutlehria S; Chowdhury N; Singh M
    Drug Deliv Transl Res; 2019 Aug; 9(4):816-827. PubMed ID: 30924025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Pharmacokinetic Considerations of Loratadine Nanoformulations and its Combinations for Pancreatic Cancer Chemoprevention.
    Desai P; Wang KZ; Ann D; Wang J; Prabhu S
    Pharm Res; 2020 Jan; 37(2):21. PubMed ID: 31897616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Nrf2 by Sulforaphane Inhibits High Glucose-Induced Progression of Pancreatic Cancer via AMPK Dependent Signaling.
    Chen X; Jiang Z; Zhou C; Chen K; Li X; Wang Z; Wu Z; Ma J; Ma Q; Duan W
    Cell Physiol Biochem; 2018; 50(3):1201-1215. PubMed ID: 30355942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells.
    Nair S; Hebbar V; Shen G; Gopalakrishnan A; Khor TO; Yu S; Xu C; Kong AN
    Pharm Res; 2008 Feb; 25(2):387-99. PubMed ID: 17657594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive Activities of Sulforaphane and Its Metabolites in Human Hepatoma HepG2 Cells.
    Liu P; Wang W; Zhou Z; Smith AJO; Bowater RP; Wormstone IM; Chen Y; Bao Y
    Nutrients; 2018 May; 10(5):. PubMed ID: 29747418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent sulforaphane and eugenol induces differential effects on human cervical cancer cells.
    Hussain A; Priyani A; Sadrieh L; Brahmbhatt K; Ahmed M; Sharma C
    Integr Cancer Ther; 2012 Jun; 11(2):154-65. PubMed ID: 21382956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
    Rathod VR; Shah DA; Dave RH
    Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.